Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Myhr

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2015
Genetic ablation of androgen receptor signaling in fetal Leydig cell lineage affects Leydig cell functions in adult testisElena M Kaftanovskaya, Carolina Lopez, Lydia Ferguson, et al.
Biochemical Pharmacology|June 30, 2024
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technologyIrina U Agoulnik, Elena M Kaftanovskaya, Courtney Myhr, et al.
Biochemistry|February 12, 2016
Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule AgonistsXin Hu, Courtney Myhr, Zaohua Huang, et al.
Journal of the Endocrine Society|August 22, 2017
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290Elena M Kaftanovskaya, Mariluz Soula, Courtney Myhr, et al.
Diabetes|July 18, 2015
Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 DiabetesSong Xue, Amanda Posgai, Clive Wasserfall, et al.
Diabetes|August 17, 2011
Reduced serum vitamin D-binding protein levels are associated with type 1 diabetesDustin Blanton, Zhao Han, Lindsey Bierschenk, et al.
Frontiers in Endocrinology|September 9, 2015
Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290Zaohua Huang, Courtney Myhr, Ross A D Bathgate, et al.
European Journal of Medicinal Chemistry|July 15, 2018
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profileKenneth J Wilson, Jingbo Xiao, Catherine Z Chen, et al.
Communications Biology|November 5, 2022
Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2Maria Esteban-Lopez, Kenneth J Wilson, Courtney Myhr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M Kaftanovskaya, Hooi Hooi Ng, Mariluz Soula, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2015
Genetic ablation of androgen receptor signaling in fetal Leydig cell lineage affects Leydig cell functions in adult testisElena M Kaftanovskaya, Carolina Lopez, Lydia Ferguson, et al.
Biochemical Pharmacology|June 30, 2024
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technologyIrina U Agoulnik, Elena M Kaftanovskaya, Courtney Myhr, et al.
Biochemistry|February 12, 2016
Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule AgonistsXin Hu, Courtney Myhr, Zaohua Huang, et al.
Journal of the Endocrine Society|August 22, 2017
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290Elena M Kaftanovskaya, Mariluz Soula, Courtney Myhr, et al.
Diabetes|July 18, 2015
Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 DiabetesSong Xue, Amanda Posgai, Clive Wasserfall, et al.
Diabetes|August 17, 2011
Reduced serum vitamin D-binding protein levels are associated with type 1 diabetesDustin Blanton, Zhao Han, Lindsey Bierschenk, et al.
Frontiers in Endocrinology|September 9, 2015
Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290Zaohua Huang, Courtney Myhr, Ross A D Bathgate, et al.
European Journal of Medicinal Chemistry|July 15, 2018
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profileKenneth J Wilson, Jingbo Xiao, Catherine Z Chen, et al.
Communications Biology|November 5, 2022
Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2Maria Esteban-Lopez, Kenneth J Wilson, Courtney Myhr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M Kaftanovskaya, Hooi Hooi Ng, Mariluz Soula, et al.
Pageof 2